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Although anxiety disorders are among the most prevalent of psychiatric disorders, childhood
trauma-related studies seldom consider anxiety proneness as distinct aetiological contribu-
tor. We aimed to distinguish between trauma- and anxiety-associated physiological profiles.
South African adolescent volunteers were categorised for trauma exposure (CTQ, mean
score 39±11) and anxiety proneness (AP)(CASI, mean score 37±7, STAI-T, mean score 41
±8). Circulating hormone and leukocyte glucocorticoid receptor levels, as well as leukocyte
functional capacity, were assessed. AP was associated with lower DHEAs (P<0.05) and
higher leukocyte GR expression (P<0.05). DHEAs was also negatively correlated with anxi-
ety sensitivity (CASI, P<0.05). In conclusion, AP may have more predictive power than
trauma in terms of health profile. Increased glucocorticoid sensitivity previously reported
after trauma, may be a unique function of anxiety and not trauma exposure per se. DHEAs
concentration was identified as potentially useful marker for monitoring progressive changes
in HPA-axis sensitivity and correlated with psychological measures of anxiety.
Introduction
The advent of modernity raised the general quality of life. However, there are still many people
who live in high risk environments, especially in developing countries such as South Africa.
Lower socioeconomic standing increases the likelihood of experiencing negative life events
and children and young adults in particular are at risk of experiencing early life trauma and
poorer health outcomes [1,2]. [3,4] Similarly, behavioural and emotional problems are now
common in young children globally [5]. The onset of an anxiety disorder is typically in child-
hood or early adolescence [6]. In this context, a history of childhood maltreatment has been
consistently linked to an increased risk for development of an anxiety disorder [7,8]. Further-
more, anxiety disorders have also been associated with anxiety proneness [9], a function of
anxiety sensitivity and trait anxiety [10], which has also been implicated as risk factor for poor
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performance in neuropsychological domains [11]. From the trauma literature, it is clear that
there is high prevalence of anxiety developing as an outcome to trauma exposure. Therefore, it
is easy to view anxiety as a symptom of trauma exposure and to overlook the role that pre-
existing anxiety may play in health outcome independently of the trauma.
We believe that a relative inconsideration for anxiety as confounder, may explain at least in
part, the disparity in physiological maladaptation reported to result from trauma exposure. A
representative summary of literature illustrating this disparity is presented in Table 1.
Although there is also variability between studies in terms of the general cohort characteristics,
the disease context, and the subtype of trauma involved, the inconsistency (and sometimes
even contradictory nature) of effects reported is in line with an interpretation of anxiety as
potential major confounder of health outcome. Of direct relevance to the current study, sys-
temic maladaptive effects of trauma are commonly ascribed to the dysfunction of the hypotha-
lamic-pituitary-adrenal (HPA) -axis [12]. However, similarly, studies reporting on (non-
trauma) anxiety-linked maladaptation also implicate HPA-axis dysfunction (most commonly
in terms of cortisol or glucocorticoid receptor levels) as central maladaptive mechanism
[13,14]. Furthermore, in terms of the pro-inflammatory phenotype shift that is linked to HPA-
axis dysregulation, upregulation of inflammatory markers such as interleukin -6 (IL-6) has
been reported in the context of trauma [15,16,17], with similar findings in anxiety related
research [18,19]. Taken together, the contradictory data on trauma-associated health outcome
and the similarities between trauma and anxiety in terms of reported pro- and anti-inflamma-
tory signalling, suggests that anxiety–in isolation or as component of trauma–may be a more
important driver of the physiological changes commonly ascribed to trauma, than trauma
itself.
In further support of this argument, in the non-trauma literature, it has long been known
that anxiety is implicated in the aetiology of chronic disease. For example, in a previous report
of increased prevalence of chronic disease (e.g. diabetes, arthritis, cardiac pathology) in indi-
viduals suffering from generalised anxiety disorder, the authors argued that anxiety symptoms
should not be discounted as a mere by-product of other “medical illness” [25]. More recently,
associations between the prevalence of anxiety and multi-morbidity was reported in older
adults [26]. These respected authors cautioned that the causative direction of this association
can only be confirmed by prospective studies. From these reports, it is clear that the presence
of anxiety–regardless of its cause–impacts significantly on longer term health outcome.
Turning attention to the specific population most at risk of adverse health outcome after
trauma, adolescents are at a critical stage where early life experiences are being manifested
within a more adult-like neurocognitive paradigm [27]. Furthermore, at adolescent age, a
shorter time period has passed from the trauma exposure to assessments made, so that allo-
static load is a lesser confounding factor than in adults. Considering these facts, as well as the
fact that anxiety-disorders manifest during early adulthood, an adolescent population is the
ideal population in whom to study maladaptation before clinical disease onset, so that appro-
priate avenues for intervention may be elucidated.
Childhood maltreatment trauma in particular has been associated with severe and lasting
effects on behavioural and emotional functioning [28]. The most drastic effects occur within
the cortical and limbic systems predominantly, with the amygdala, hippocampus and prefron-
tal cortex showing structural alterations that correlate with maltreatment measures [28,29,30].
Although there seems to be sufficient evidence to suggest significant alterations to brain matter
density and structure, there are still some gaps within the literature with regard to the specific
changes associated with specific subtypes of trauma and how these relate to the physiological
changes reported after trauma exposure. This becomes relevant when considering that differ-
ential mechanisms are responsible for the volumetric changes associated with trauma
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Table 1. Representative summary of literature illustrating contradictory results reported for anxiety and trauma in the context of physiological dysregulation.
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[29,31,32]. Furthermore, there may be some overlap between the physiological mechanisms
responsible for the above-mentioned changes in the brain and mechanisms that alter inflam-
matory signalling in the context of chronic stress, where the chronic stress is due to childhood
trauma exposure [33,34]. Again, this speaks to the possibility that the driving mechanisms
underlying the neuropsychological changes seen in the context of trauma may be intrinsically
linked to the specific physiological changes that occur as result of the anxiety paradigm that
usually accompanies the experience of trauma.
Therefore, the current study aimed to show the importance of anxiety–which may precede
trauma exposure–as causative factor in adaptations of physiological parameters commonly attrib-
uted to trauma exposure. Known subtypes of anxiety, as well as childhood trauma exposure sever-
ity, was correlated to physiological maladaptation in biological systems in an attempt to point out
the relative importance of anxiety in determining health outcome in the context of trauma.
Materials and methods
Participant recruitment and ethical considerations
1149 Participants (16–18 years of age) were recruited by systematic random sampling from 31
government schools around Cape Town, South Africa, after obtaining ethical clearance from
the Stellenbosch University Human Research Ethics Committee (Reference number: N11/04/
131) and permission from the provincial Department of Education. Written informed assent
was obtained from all participants, as well as from parents/legal guardians. Research was con-
ducted in accordance to The Declaration of Helsinki.
Recognizing that there are potential confounding factors such as socio-economic status,
individual resilience, social and familial support, etc., a particular strength of the current study
is that the study cohort was selected from a particularly homogenous demographic, with very
similar cultural background, level of formal education, income and ethnicity.
Psychiatric evaluation and experimental grouping of subjects
All participants were pre-screened for trauma exposure, as well as depression, and alcohol and
drug use (the latter three potential confounders were employed as exclusion criteria), using the
results of the Centre for Epidemiological Studies Depression Scale for children (CES-DC) [35],
Alcohol Use Disorders Identification Test (AUDIT) [36], Drug Use Disorders Identification
Test (DUDIT) [37], Adolescent Coping Orientation for Problem Experiences (A-COPE) [38],
childhood maltreatment and anxiety-related traits using the Childhood Trauma Questionnaire
(CTQ-SF) [39], Child Anxiety Sensitivity Index (CASI) [40] and the trait section of the State-
Trait Anxiety Inventory (STAI) [41]. Internal consistency values for these tests have been pub-
lished elsewhere [42]. Using scores of the CTQ, as well as a composite score of the STAI-T and
CASI as a measure of AP, adolescents were classified as follows: a) high childhood maltreat-
ment/trauma and high anxiety-prone (upper 66th percentile for both variables, HI-HI), b)
high childhood maltreatment/trauma and low anxiety-prone (upper 66th percentile for
Table 1. (Continued)
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childhood maltreatment/trauma and lower 66th percentile for anxiety proneness, HI-LO), c)
low childhood maltreatment/trauma and high anxiety-prone (lower 66th percentile for child-
hood maltreatment/trauma and upper 66th percentile for anxiety proneness, LO-HI) and d)
low childhood maltreatment/trauma and low anxiety-prone (lower 66th percentile for both
variables, LO-LO). These participants were re-screened by means of a structured diagnostic
interview conducted by a qualified research psychologist (LM) to screen for the presence of
anxiety and mood disorders using the Mini-International Neuropsychiatric Interview-Kid for
children and adolescents (MINI-KID; [43]), which follows the Diagnostic and Statistical Man-
ual of Mental Disorders-IV [44] and WHO International Classification of Diseases-10 (1992)
criteria for the diagnosis of psychiatric disorders, screening for 17 Axis I disorders. In addition,
confirmation of group status and compliance with inclusion and exclusion criteria were con-
firmed by administration of the Children’s Depression Inventory (CDI) [45], the Adolescent
Drinking Inventory (ADI) [46] and the multidimensional Anxiety Scale for Children (MASC)
[47]. Questionnaire scores and psychological assessment outcome measures have been com-
prehensively reported in association with neuropsychological test results for the larger group
[11]. For the purpose of this study, a subgroup of 43 participants were randomly selected (limi-
tation of sample size was required due to high analytical cost). Final size of experimental
groups were as follows: HI-HI, n = 9; HI-LO, n = 12; LO-HI, n = 9 and LO-LO, n = 13.
Blood sample collection and analysis
Early morning fasted blood samples were obtained for isolation of peripheral blood mononu-
clear cells (PBMCs) and serum analysis for cortisol, prolactin, dehydroepiandrosterone-sul-
phate (DHEAs) and testosterone levels by automated analysis by automated analysis in
pathology laboratory (Pathcare), using standard laboratory procedures.
In addition, whole blood was analysed for leukocyte immunophenotyping and intracellular
GR expression using flow cytometry (FASCAria, BD Biosciences, USA). The following mono-
clonal antibodies were used: FITC-conjugated anti-GR, PE-conjugated anti-CD56 (for NK
cells), Alexa Fluor anti-CD19 (for B cells), APC-C7 CD3 (for T cells) and BV421 CD14 (for
monocytes) (Biolegend, USA).
In order to properly gate and identify cells, single stain controls and fluorescence minus
one (FMO) controls were employed to determine the demarcation of the true positive and
negative populations for the markers of interest. For the compensation, Anti-Mouse Ig Comp-
Beads (BD Biosciences, USA) were employed. Cytometer setup and tracking (QC) beads and
8-peak beads were run to ensure instrument linearity. Lastly, an unstained control for each
participant was included. For cell staining, the CytoFix/CytoPerm kit was used according to
manufacturer’s instructions (BD Biosciences, San Jose, USA).
Cell surface staining was performed by incubating 50 μl of whole blood with 5 μl of each
monoclonal antibody in the dark for 30 minutes at room temperature. After incubation, eryth-
rocytes were lysed using BD FACSLyse (BD Biosciences, San Jose, USA), washed with the BD
CytoPerm buffer and pelleted at 600xg for 5 minutes. The cells were then re-suspended in BD
CytoFix buffer for at 4˚C for 20minutes. Thereafter, the cells were washed again, before50μl of
CytoPerm—with a predetermined optimal concentration (2�66 μg/ml) of anti-GCR MoAb—
was added and cells incubated at 4˚C for 20 min in the dark. After washing, to remove any
unbound antibodies, the cell pellets were resuspended in 500 μl of 4% paraformaldehyde in
PBS and run on the flow cytometer. All analyses were acquired using BD FACSDiva software
v6.1.3. A total of 1000 000 events were acquired in the light scatter (FSC/SSC) gate. The fluo-
rescence intensities of GCR-labelled leukocyte populations were displayed and determined as
median fluorescent intensity (MFI) values on four-decade histogram plots.
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Absolute cell counts were calculated for leukocyte subpopulations that were analysed using
flow cytometry. These were derived from a total WBC and lymphocyte count obtained by
automated hematology analysis (Celldyne 3700CS), as well as the respective percentages of
cells of the lymphocyte gates obtained during flow cytometry analysis. Furthermore, as a qual-
ity control (QC) step, the calculated absolute counts of subpopulations were also added
together and did sum to the total lymphocyte count.
Peripheral blood mononuclear cell functional capacity
PBMCs were isolated from whole blood by density gradient centrifugation using Histopaque
(Sigma Aldrich, 10771). PBMCs were seeded at 200 000 cells/well in RPMI and stimulated
with either media (control) or LPS (Lipopolysaccharide) (50ng/ml) for 6 hours at 37˚C. At the
end of the 6hr stimulation period, cells were pelleted, supernatant removed and frozen at
−80˚C. Subsequently batch analysis for concentrations of IL-1β, IL-6, IL-10 and TNF-α
(Tumour Necrosis Factor alpha) (detection limits respectively 0.8, 0.9, 1.1 and 0.7 pg/ml) was
performed, using Milliplex MAP Human Cytokine Kits (cat# HCYTOMAG-60K, Merck,
Darmstadt, Germany) and a Bio-Plex 200 Array Reader (Bio-Rad, Hercules, CA, USA).
Statistical analysis
Both experimental grouping of subjects and data analysis were performed in consultation with
Prof Martin Kidd, an experienced biostatistician (Centre for Statistical Consultation, Stellen-
bosch University). Depending on normalcy of data distribution, either parametric or non-
parametric two-way ANOVA was used to determine main effects, followed by Fisher LSD post
hoc testing. For analysis of relationships between parameters, Spearman rank correlation coef-
ficients were calculated. As additional test for robustness, linear regression analyses were per-
formed. Given the fact that multiple comparisons were calculated for complimentary
parameters, no correction was required. [48,49] In these analyses gender, anxiety proneness
and trauma exposure severity was used as fixed effects, with subject nested in gender�trau-
ma�anxiety as random effect.
Results
The validity of questionnaires used for experimental grouping of individuals was evident from
results obtained, which clearly indicated significantly higher CASI scores in individuals classi-
fied as high anxiety prone, while individuals classified as hi trauma exposed scored signifi-
cantly higher in the CTQ (Table 2). Similarly, our decision to use the composite score for trait
anxiety and anxiety sensitivity—anxiety proneness–as anxiety measure in the current study, is
validated by the fact that trait anxiety and anxiety sensitivity scores, which were significantly
correlated to each other (R = 0.56, P<0.05), were differentially correlated with physiological
measures. Anxiety sensitivity was most often correlated with leukocyte counts Pearson coeffi-
cient calculation returned correlations between AS and both Eosinophils and Basophils
(Eosinophils, Pearson R = -0.3; Basophils, Pearson R = -0.33, P<0.05). Regression analysis sup-
ported this and suggested an additional correlation between AS and Monocyte count (Mono-
cytes, F = 6.37, P = 0.016; Eosinophil, F = 4.14, P = 0.048; Basophil, F = 5.092, P = 0.029) In
contrast, trait anxiety was more closely correlated with leukocyte GR levels (B Lymphocyte
GR, Pearson R = 0.33; Natural Killer Cell GR, Pearson R = 0.36; Monocyte GR, Pearson
R = 0.34, P<0.05). Regression analysis supported this finding (B Lymphocyte GR, F = 4.95,
P = 0.032; Natural Killer Cell GR, F = 6.23, P = 0.017; Monocyte GR, F = 5.47, P = 0.024) Since
glucocorticoid sensitivity is determined by both the GR level on any individual cell and the
total number of cells available to present GR for glucocorticoid binding, the composite score
PLOS ONE Anxiety contributes to chronic disease development
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of anxiety proneness is arguably the most accurate anxiety-related measure to use in data
reduction and interpretation, at least in the current study.
Main findings from current data suggests that physiological outcomes commonly accepted
to result from trauma exposure, seemed more consistently associated with anxiety–both state
and trait–than with trauma.
Association of anxiety proneness with glucocorticoid receptor expression
A marked increase in expression of GR was seen in AP in all white blood cell (WBC) subpopula-
tions assessed (Fig 1). (Interestingly, when correlating either trait anxiety or anxiety sensitivity
to GR levels separately, correlations seen with mainly trait anxiety was less consistent than
reported here for AP). Childhood trauma severity (when grouping was done according to total
CTQ score) did not influence GR expression statistically. However, it did seem to have an effect
on the magnitude of increase associated with anxiety. In the two groups with low AP, values for
GR expression were similar. However, in the presence of higher AP, the anxiety-associated
increase in GR expression was consistently higher in the low-trauma vs. the high-trauma group
(Fig 1), suggesting that trauma exposure may blunt the GR response to anxiety to some extent.
A confirmation of these results—suggestive of somewhat opposing effects of anxiety and
trauma—is elucidated when all subjects are grouped together and correlation coefficients was
calculated across the continuum for GR expression vs. CTQ, STAI-T and CASI (Table 3).
Here, CASI-Physical concerns showed a consistent tendency for a positive correlation with
GR expression for all of the cell types assessed, while a consistent negative correlation of
CTQ-Physical neglect with B cell (Spearman P = -0.05; R = -0.3), NK cell (P = -0.05; R =
-0.29), and T cell (P = -0.03; R = -0.33) GR expression levels became evident.
DHEAs, rather than cortisol, identified as most useful endocrine marker
for AP
In terms of serum testosterone levels, there was a main effect of gender, as anticipated, with
males exhibiting significantly higher basal testosterone levels than females (21.8 ± 1.3 vs.
Table 2. Accuracy of subject grouping is reflected by significant ANOVA main effects for trauma exposure (CTQ) and anxiety proneness (combined STAI-T and









ANOVA effect of trauma
exposure F(1,41); P-value
ANOVA effect of anxiety
proneness F(1,41); P-value
STAI-T 52 ± 7 39 ± 3 46 ± 6 33 ± 6 F = 5.59; p < 0.01 F = 43.96; p < 0.000001
CASI total 42 ± 4 31 ± 4 45 ± 4 33 ± 7 F = 0.61; p = 0.17 F = 56,66; p < 0.000001
CASI Social Concerns 12 ± 1 9 ± 2 12 ± 1 10 ± 2 F = 0.06; p = 0.87 F = 17.47; p < 0.001
CASI Psychological
Concerns
6 ± 1 5 ± 2 7 ± 2 4 ± 1 F = 0.02; p = 0.93 F = 23.18; p < 0.0001
CASI Physical
Concerns
23 ± 3 17 ± 3 26 ± 2 18 ± 3 F = 1.39, p = 0.24 F = 47.28; p < 0.000001
CTQ total 50 ± 11 44 ± 9 33 ± 8 31 ± 5 F = 30.42; p < 0.00001 F = 1.54; p = 0.22
CTQ Physical neglect 10 ± 3 9 ± 4 8 ± 3 6 ± 1 F = 7.52; p = 0.01 F = 1.23; p = 0.27
CTQ Emotional abuse 12 ± 5 9 ± 4 6 ± 2 6 ± 1 F = 13.09; p < 0.001 F = 1.73; p = 0.20
CTQ Emotional
neglect
13 ± 4 13 ± 5 9 ± 4 8 ± 3 F = 12.92; p < 0.001 F = 0.14; p = 0.72
CTQ Physical abuse 9 ± 4 7 ± 3 5 ± 0 5 ± 0 F = 12.82; p < 0.001 F = 1.24; p = 0.27
CTQ Sexual abuse 6 ± 2 6 ± 1 5 ± 0 5 ± 1 F = 4.57; p = 0.03 F = 0.00; p = 1.00
Statistical data is presented as F-values; P-values. NS = no significant effect
https://doi.org/10.1371/journal.pone.0230053.t002
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2.3 ± 1.0 nmol/L, ANOVA main effect P<0.00001). Testosterone was not further analysed sta-
tistically for males, due to low subject number (n = 11). For females, testosterone levels were
not related to either trauma or AP.
Fig 1. Consistent effect of anxiety proneness on glucocorticoid receptor (GR) expression in leukocyte subpopulations. Statistics: # = ANOVA main
effect of AP, Abbreviations: AU, arbitrary units; MFI, mean fluorescent intensity.
https://doi.org/10.1371/journal.pone.0230053.g001
Table 3. Correlations of glucocorticoid receptor expression with trait anxiety, anxiety sensitivity (and subscales) and trauma (and subscales).

























































































Data is presented as Spearman r-values (P-values). Significant values and trends are indicated in bold font.
GR = glucocorticoid MFI = mean fluorescent intensity; NK = natural killer cell; T lymph = T lymphocyte; Mono = monocyte
https://doi.org/10.1371/journal.pone.0230053.t003
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While both serum prolactin and cortisol levels were within normal ranges and not influ-
enced by either trauma or AP, high AP was associated with decreased DHEAs (ANOVA main
effect, P<0.05; Fig 2). The latter effect was largely due to a major inhibitory effect in anxiety
prone individuals without trauma (Fischer LSD post hoc LO-LO vs LO-HI, P = 0.01). Of fur-
ther importance is the fact that a large portion of this population presented with below-normal
DHEAs concentrations: 67% of HI-HI, 75% of HI-LO, 100% of LO-HI and 62% of LO-LO.
Also, when correlations across the group as a whole were considered, CASI-Total, CASI-Physi-
cal concerns and CASI-Psychological concerns were negatively correlated with basal DHEAs
levels (P<0.05, Table 4). Regression analysis confirmed this interpretation (supplementary
material).
Fig 2. Effect of anxiety proneness and trauma exposure on serum dehydroepiandrosterone-sulfate (DHEAs),
cortisol and prolactin levels.
https://doi.org/10.1371/journal.pone.0230053.g002
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IL-10 modulation in response to LPS stimulation
In terms of ex-vivo cytokine production in response to LPS stimulus no significant effects of
either anxiety proneness or trauma history were detected for pro-inflammatory cytokines
TNF-α, IL-1β or IL-6, although the relatively high variability of current data (not shown) pre-
cludes firm conclusions. In terms of the anti-inflammatory IL-10 specifically, average LPS-
induced production levels were highest in the low trauma, low AP group (36.9 ± 8.96 pg/ml),
while in comparison, either presence of high trauma (9.7 ± 3.87 pg/ml, P<0.01) or high AP
(11.4 ± 6.60 pg/ml, P<0.01) significantly inhibited IL-10 production. The effects of trauma
and AP did not appear to be additive (11.3 ± 3.88 pg/ml in high AP, high trauma, P<0.01
when compared to low AP, low trauma).
Discussion
By simultaneous assessment of physiological and psychological parameters, the current study
was able to point out a significant oversight in the literature and identify a potential tool in
monitoring the physiological progression of anxiety. Despite the fact that analytical costs lim-
ited the subject number somewhat, we are confident that our data analysis was sufficiently
stringent and our interpretation of current data sufficiently conservative.
The broader literature clearly supports very different profiles for anxiety and trauma when
viewed as separate entities. Although in both conditions variable results for cortisol concentra-
tion in circulation have been reported, anxiety generally involves increased CRH and/or GR
expression levels and enhanced Dex suppression (denoting enhanced negative central feed-
back). Interestingly, these physiological features has been reported for both PTSD (e.g. [50])
and melancholia [51], where the construct of anxiety underlies both disorders. In contrast,
decreased CRH and/or GR expression levels as well as Dex suppression being overridden
(denoting impaired negative central feedback) has been associated with chronic stress (not
burn-out) and major or atypical depression (e.g. [52,53]), where anxiety does not necessarily
play a major role. Despite these contrasting physiological outcomes reported for anxiety and
stress, the confounding effect of anxiety seem to have been largely ignored in studies on
trauma exposure–specifically also childhood maltreatment–where the majority of reports fail
to even report anxiety levels of individuals. This may explain the contradicting results reported
for trauma and the similar effects that have been reported for trauma and anxiety (Table 1). In
the current study, an attempt was made to distinguish between anxiety and trauma, and to dif-
ferentially correlate these measures to physiological outcome parameters. Current data suggest
that, in a South African adolescent population with a history of childhood maltreatment, the
level of trauma exposure may have a relatively insignificant role to play in central information
processing and physiological outcome parameters, when compared to the predictive power of
anxiety proneness. This major, novel result highlights the importance of considering anxiety
or anxiety proneness as potential confounding factor when assessing effects of childhood
trauma.
In terms of endocrine parameters assessed, cortisol has commonly been assessed in the con-
text of stress and allostasis (e.g. as reviewed by [54]), although not in populations presenting
with subclinical anxiety, as reported on here. In contrast, dehydroepiandrosterone (DHEA)
has only been investigated significantly in models of ageing [55]–where ageing is associated
with decreased DHEA concentration—and PTSD, for which literature is growing, but contra-
dictory. In the context of PTSD, a recent study reported increased DHEA levels in war
trauma-exposed individuals with PTSD when compared to non-trauma exposed controls [56].
However, in a Serbian study, DHEA levels was reported to be lower in patients with PTSD
when compared to non-PTSD trauma-exposed individuals [57]. Interestingly, and relevant to
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the current discussion, the authors concluded that DHEA failed as trauma indicator, as it was
found to be significantly influenced by personality. In terms of adolescent PTSD, both acute
(single event rape) and chronic (repeated sexual abuse) trauma was reported to be associated
with decreased DHEA concentrations [58,59]. Current data similarly indicates DHEAs levels
below the expected normal range for the majority of study participants with high anxiety
proneness in the absence of trauma exposure. The low DHEAs may indicate adrenal burnout/
allostasis in these individuals, which may point towards an AP-dependent hypoactivity of the
lower (excluding the hypothalamus) HPA-axis, which alarmingly is already evident during
adolescence. This result is particularly significant, in light of the existing theory of a trajectory
from hyper- to hyposensitivity to glucococortioids and the resultant hyper- to hypocortisolism
in response to years of childhood maltreatment [60,61]. The fact that DHEA, but not cortisol,
showed significant predictive power in the context of AP, is significant. The fact that trauma
exposure in the current study, seemed to counter anxiety-related decreases in DHEA, suggests
that at least some studies reporting on trauma, may in fact be measuring effects of anxiety,
accounting for the contradictory literature. The fact that DHEAs does not have a potentially
confounding major role in metabolism, which cortisol does, probably contributes to this result.
The consistency of current data implicating DHEAs as sensitive marker in the context of anxi-
ety proneness, warrants further purpose-designed investigation to assess the potential of
DHEAs as marker for monitoring anxiety-related progressive changes in HPA-axis sensitivity.
In addition, the possibility of using relatively increased DHEAs levels as “warning” indicator
in trauma studies to indicate high risk of anxiety as confounding effect, should be investigated.
In terms of the IL-10 result, maladapted cytokine responses have long been implicated in psy-
chological disorders, including depression and anxiety [62,63]. Current results are in agreement
with the literature. For example, in a study of over 100 adults [64], anxiety and depression were
linked to a relatively more pro-inflammatory profile. Also, chronically stressed mice exhibited
decreased hippocampal IL-10 expression [65], while pro-inflammatory cytokine responses were
unaltered–as also reported in the current study. Current data is the first to our knowledge, to report
IL-10 maladaptation already present in adolescents exposed to childhood maltreatment and/or
having high anxiety proneness, in the absence of other apparent causative factors or pathology.
In line with DHEA and IL-10 data, leukocyte glucocorticoid receptor (GR) expression was
consistently elevated with AP. This enhanced leukocyte glucocorticoid responsiveness/sensi-
tivity is in line with studies on PTSD (e.g. [66]_40ew0vw) but contrasts with the literature on
models of chronic stress, where GR is generally down-regulated [67]. In our study, trauma
seemed to mildly blunt the AP-induced increase in GR expression consistently across all leu-
kocyte sub-populations. This may suggest that with chronic stress, GR expression may be
down-regulated in response to chronically raised cortisol levels. Hence, increased glucocorti-
coid sensitivity may be a unique function of anxiety and not trauma exposure. Therefore, we
suggest that trauma-focused literature (e.g. related to PTSD and childhood maltreatment) be
revisited, to assess whether effects previously ascribed to trauma may in fact be due to AP.
We acknowledge the limitations posed by the relatively small (n = 43) sample size. How-
ever, as mentioned, the cohort is robust and homogenous for potential confounders such as
socio-economic factors. Nevertheless, to truly dissect the relative contribution of anxiety to
health outcome when compared to that resulting from trauma directly, a larger cohort study is
preferable.
Conclusion
Data indicates that in our adolescent population, anxiety proneness exhibited a greater associa-
tion with physiological profile than childhood maltreatment. Current data further highlight
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the potential of DHEAs as useful tool for monitoring and/or managing at risk populations in
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